Global Novel Oral AntiCoagulants (NOAC) Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3485470
- 97 Pages
- January 2020
- Healthcare
The global Novel Oral AntiCoagulants (NOAC) market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Novel Oral AntiCoagulants (NOAC) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Direct Thrombin Inhibitors
Direct Factor Xa Inhibitors
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Johnson & Johnson
Bristol-Myers Squibb
Boehringer Ingelheim
Sanofi
Daiichi Sankyo
Armatheon
Aspen
AstraZeneca
Bayer
Cellceutix
Cosmo Pharmaceuticals
CSL Behring
Eisai
GSK
Marathon Pharmaceuticals
Ockham Biotech
Perosphere
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Deep Vein Thrombosis (DVT)
Pulmonary Embolism
Acute Coronary Syndrome
Hemodialysis
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Novel Oral AntiCoagulants (NOAC) Industry
Figure Novel Oral AntiCoagulants (NOAC) Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Novel Oral AntiCoagulants (NOAC)
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Novel Oral AntiCoagulants (NOAC)
1.2.2 Downstream
Table Application Segment of Novel Oral AntiCoagulants (NOAC)
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Novel Oral AntiCoagulants (NOAC) Market by Type
3.1 By Type
3.1.1 Direct Thrombin Inhibitors
Table Major Company List of Direct Thrombin Inhibitors
3.1.2 Direct Factor Xa Inhibitors
Table Major Company List of Direct Factor Xa Inhibitors
3.2 Market Size
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Type, in USD Million
Figure Global Novel Oral AntiCoagulants (NOAC) Market Growth 2015-2019, by Type, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Type, in Volume
Figure Global Novel Oral AntiCoagulants (NOAC) Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Type, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Johnson & Johnson (Company Profile, Sales Data etc.)
4.1.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.1.2 Johnson & Johnson Products & Services
4.1.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Bristol-Myers Squibb (Company Profile, Sales Data etc.)
4.2.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
4.2.2 Bristol-Myers Squibb Products & Services
4.2.3 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.3.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.3.2 Boehringer Ingelheim Products & Services
4.3.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sanofi (Company Profile, Sales Data etc.)
4.4.1 Sanofi Profile
Table Sanofi Overview List
4.4.2 Sanofi Products & Services
4.4.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.5.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.5.2 Daiichi Sankyo Products & Services
4.5.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Armatheon (Company Profile, Sales Data etc.)
4.6.1 Armatheon Profile
Table Armatheon Overview List
4.6.2 Armatheon Products & Services
4.6.3 Armatheon Business Operation Conditions
Table Business Operation of Armatheon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Aspen (Company Profile, Sales Data etc.)
4.7.1 Aspen Profile
Table Aspen Overview List
4.7.2 Aspen Products & Services
4.7.3 Aspen Business Operation Conditions
Table Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 AstraZeneca (Company Profile, Sales Data etc.)
4.8.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.8.2 AstraZeneca Products & Services
4.8.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Bayer (Company Profile, Sales Data etc.)
4.9.1 Bayer Profile
Table Bayer Overview List
4.9.2 Bayer Products & Services
4.9.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Cellceutix (Company Profile, Sales Data etc.)
4.10.1 Cellceutix Profile
Table Cellceutix Overview List
4.10.2 Cellceutix Products & Services
4.10.3 Cellceutix Business Operation Conditions
Table Business Operation of Cellceutix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Cosmo Pharmaceuticals (Company Profile, Sales Data etc.)
4.11.1 Cosmo Pharmaceuticals Profile
Table Cosmo Pharmaceuticals Overview List
4.11.2 Cosmo Pharmaceuticals Products & Services
4.11.3 Cosmo Pharmaceuticals Business Operation Conditions
Table Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 CSL Behring (Company Profile, Sales Data etc.)
4.12.1 CSL Behring Profile
Table CSL Behring Overview List
4.12.2 CSL Behring Products & Services
4.12.3 CSL Behring Business Operation Conditions
Table Business Operation of CSL Behring (Sales Revenue, Cost, Gross Margin)
4.13 Eisai (Company Profile, Sales Data etc.)
4.13.1 Eisai Profile
Table Eisai Overview List
4.13.2 Eisai Products & Services
4.13.3 Eisai Business Operation Conditions
Table Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 GSK (Company Profile, Sales Data etc.)
4.14.1 GSK Profile
Table GSK Overview List
4.14.2 GSK Products & Services
4.14.3 GSK Business Operation Conditions
Table Business Operation of GSK (Sales Revenue, Cost, Gross Margin)
4.15 Marathon Pharmaceuticals (Company Profile, Sales Data etc.)
4.15.1 Marathon Pharmaceuticals Profile
Table Marathon Pharmaceuticals Overview List
4.15.2 Marathon Pharmaceuticals Products & Services
4.15.3 Marathon Pharmaceuticals Business Operation Conditions
Table Business Operation of Marathon Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.16 Ockham Biotech (Company Profile, Sales Data etc.)
4.16.1 Ockham Biotech Profile
Table Ockham Biotech Overview List
4.16.2 Ockham Biotech Products & Services
4.16.3 Ockham Biotech Business Operation Conditions
Table Business Operation of Ockham Biotech (Sales Revenue, Cost, Gross Margin)
4.17 Perosphere (Company Profile, Sales Data etc.)
4.17.1 Perosphere Profile
Table Perosphere Overview List
4.17.2 Perosphere Products & Services
4.17.3 Perosphere Business Operation Conditions
Table Business Operation of Perosphere (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue 2015-2019, by Company, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Revenue Share in 2019, by Company, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Sales Volume 2015-2019, by Company, in Volume
Table Global Novel Oral AntiCoagulants (NOAC) Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Novel Oral AntiCoagulants (NOAC) Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Novel Oral AntiCoagulants (NOAC) Market Concentration, in 2019
Figure Europe Novel Oral AntiCoagulants (NOAC) Market Market Concentration, in 2019
Figure Asia-Pacific Novel Oral AntiCoagulants (NOAC) MMarket Concentration, in 2019
Figure South America Novel Oral AntiCoagulants (NOAC) Market Concentration, in 2019
Figure Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Deep Vein Thrombosis (DVT)
Figure Novel Oral AntiCoagulants (NOAC) Demand in Deep Vein Thrombosis (DVT), 2015-2019, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Demand in Deep Vein Thrombosis (DVT), 2015-2019, in Volume
6.1.2 Demand in Pulmonary Embolism
Figure Novel Oral AntiCoagulants (NOAC) Demand in Pulmonary Embolism, 2015-2019, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Demand in Pulmonary Embolism, 2015-2019, in Volume
6.1.3 Demand in Acute Coronary Syndrome
Figure Novel Oral AntiCoagulants (NOAC) Demand in Acute Coronary Syndrome, 2015-2019, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Demand in Acute Coronary Syndrome, 2015-2019, in Volume
6.1.4 Demand in Hemodialysis
Figure Novel Oral AntiCoagulants (NOAC) Demand in Hemodialysis, 2015-2019, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Demand in Hemodialysis, 2015-2019, in Volume
6.1.5 Demand in Others
Figure Novel Oral AntiCoagulants (NOAC) Demand in Others, 2015-2019, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2020-2025, by Application, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Market Growth 2020-2025, by Application, in USD Million
Figure Novel Oral AntiCoagulants (NOAC) Market Share in 2025, by Application, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2020-2025, by Application, in Volume
Table Novel Oral AntiCoagulants (NOAC) Market Growth 2020-2025, by Application, in Volume
Table Novel Oral AntiCoagulants (NOAC) Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Novel Oral AntiCoagulants (NOAC) Production 2015-2019, by Region, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Region, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market Share 2015-2019, by Region, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Region, in Volume
Table Global Novel Oral AntiCoagulants (NOAC) Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in USD Million
Figure North America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table North America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in USD Million
Figure Europe Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table Europe Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in USD Million
Figure South America Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table South America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Region, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
Table Upstream Segment of Novel Oral AntiCoagulants (NOAC)
Table Application Segment of Novel Oral AntiCoagulants (NOAC)
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2025, by Application, in USD Million
Table Major Company List of Direct Factor Xa Inhibitors
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Type, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Type, in Volume
Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Type, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Type, in Volume
Table Johnson & Johnson Overview List
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Overview List
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Daiichi Sankyo Overview List
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Armatheon Overview List
Table Business Operation of Armatheon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Aspen Overview List
Table Business Operation of Aspen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Overview List
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer Overview List
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cellceutix Overview List
Table Business Operation of Cellceutix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Cosmo Pharmaceuticals Overview List
Table Business Operation of Cosmo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Behring Overview List
Table Business Operation of CSL Behring (Sales Revenue, Cost, Gross Margin)
Table Eisai Overview List
Table Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Overview List
Table Business Operation of GSK (Sales Revenue, Cost, Gross Margin)
Table Marathon Pharmaceuticals Overview List
Table Business Operation of Marathon Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Ockham Biotech Overview List
Table Business Operation of Ockham Biotech (Sales Revenue, Cost, Gross Margin)
Table Perosphere Overview List
Table Business Operation of Perosphere (Sales Revenue, Cost, Gross Margin)
Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue 2015-2019, by Company, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Sales Volume 2015-2019, by Company, in Volume
Table Global Novel Oral AntiCoagulants (NOAC) Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2020-2025, by Application, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Demand Forecast 2020-2025, by Application, in Volume
Table Novel Oral AntiCoagulants (NOAC) Market Growth 2020-2025, by Application, in Volume
Table Novel Oral AntiCoagulants (NOAC) Market Share in 2025, by Application, in Volume
Table Novel Oral AntiCoagulants (NOAC) Production 2015-2019, by Region, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Production 2015-2019, by Region, in Volume
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Region, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market Share 2015-2019, by Region, in USD Million
Table Global Novel Oral AntiCoagulants (NOAC) Market 2015-2019, by Region, in Volume
Table Global Novel Oral AntiCoagulants (NOAC) Market Share 2015-2019, by Region, in Volume
Table North America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table North America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
Table Europe Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table Europe Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
Table South America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table South America Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Novel Oral AntiCoagulants (NOAC) Market Size 2015-2019, by Country, in Volume
Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Region, in USD Million
Table Novel Oral AntiCoagulants (NOAC) Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
